Monday, June 15, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 314 of 1,261
  1. US 11124537

    Inhibitors of glucocorticoid receptor

    ORIC PHARMACEUTICALS, INC. · Granted Sep 21, 2021 · Expires Sep 16, 2041

    granted
  2. US 11124835

    Methods of diagnosing chronic obstructive pulmonary disease (COPD) using novel molecular biomarkers

    Transgenion—International Institute for Regenerative Translational Medicine GmbH · Granted Sep 21, 2021 · Expires Sep 16, 2041

    granted
  3. US 11124489

    EPAC antagonists

    The Board of Regents of the University of Texas System · Granted Sep 21, 2021 · Expires Sep 16, 2041

    granted
  4. US 11123285

    Auris formulations for treating OTIC diseases and conditions

    The Regents of the University of California · Granted Sep 21, 2021 · Expires Sep 16, 2041

    granted
  5. US 11123371

    Restimulation of cryopreserved tumor infiltrating lymphocytes

    Iovance Biotherapeutics, Inc. · Granted Sep 21, 2021 · Expires Sep 16, 2041

    granted
  6. WO 2021182981

    OPICAPONE MICRONISÉE

    BIAL PORTELA & Cª S A [PT] · Granted Sep 16, 2021 · Expires Sep 11, 2041

    granted
  7. CA 3174918

    OPICAPONE MICRONISEE

    BIAL PORTELA & CA SA [PT] · Granted Sep 16, 2021 · Expires Sep 11, 2041

    granted
  8. US 11117865

    Inhibitors of bromodomain-containing protein 4 (BRD4)

    The Board of Regents of the University of Texas System · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  9. US 11116798

    Universal donor cells

    CRISPR THERAPEUTICS AG · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  10. US 11118170

    Engineered clostridium botulinum toxin adapted to deliver molecules into selected cells

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  11. US 11118180

    Anti-inflammatory treatment via inhibition of endothelial cell kinesin light chain 1, variant 1 (KLC1C)

    Northwestern University · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  12. US 11117945

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  13. US 11116825

    Cancer vaccine compositions and methods of using the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  14. US 11117934

    Oncolytic virus platform to treat cancers with myxoma virus

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  15. US 11116214

    Lice control composition and method

    TYRATECH, INC. · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  16. US 11116823

    Treatment of α-galactosidase a deficiency

    Takeda Pharmaceutical Company Limited · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  17. US 11116797

    Universal donor cells

    CRISPR THERAPEUTICS AG · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  18. US 11118196

    Universal donor cells

    CRISPR THERAPEUTICS AG · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  19. US 11118195

    Universal donor cells

    CRISPR THERAPEUTICS AG · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  20. US 11118192

    Adeno-associated virus variant capsids and methods of use thereof

    4D MOLECULAR THERAPEUTICS INC. · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  21. US 11118186

    Soluble interleukin-7 receptor (sIL7R) modulating therapy to treat autoimmune diseases and cancer

    The Board of Regents of the University of Texas System · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  22. US 11116740

    Methods for use in support of planned supplement and food ingredient products for diagnosis and treatment of metabolic syndrome

    United States of America as represented by the Secretary of the Air Force · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  23. US 11118183

    Modulation of angiopoietin-like 3 expression

    Ionis Pharmaceuticals, Inc. · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  24. US 11118177

    Materials and methods for treatment of Usher syndrome type 2A and/or non-syndromic autosomal recessive retinitis pigmentosa (ARRP)

    CRISPR THERAPEUTICS AG · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.